{
    "clinical_study": {
        "@rank": "1348", 
        "brief_summary": {
            "textblock": "The main purpose of the study was to evaluate the efficacy of Levonorgestrel Releasing\n      Intrauterine devices (LNR-IUD) on genitourinary symptoms in patients with abnormal uterine\n      bleeding. The patients were asked urogenital distress inventory (UDI) (which includes;\n      irritative symptoms, stress symptoms, obstructive discomfort) and incontinence impact\n      questionnaire (IIQ) (which includes; physical activity, travel, social/relationships,\n      emotional health)questionnaires in the day of application LNR-IUD and six months later this\n      procedure. Statistical analyse will be performed to evaluate the changes in this time\n      period."
        }, 
        "brief_title": "Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine Systems", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Lower Urinary Tract Symptoms", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women using levonorgestrel releasing intrauterine device for the treatment of\n             menorrhagia or adenomyosis\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "15 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "15-55 aged women using levonorgestrel releasing intrauterine device for the treatment of\n        menorrhagia or adenomyosis"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01730300", 
            "org_study_id": "LN-IUSBDSK"
        }, 
        "intervention_browse": {
            "mesh_term": "Levonorgestrel"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Istanbul", 
                    "country": "Turkey", 
                    "zip": "34250"
                }, 
                "name": "Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Genitourinary Symptoms in Women Using Levonorgestrel Releasing Intrauterine Systems", 
        "overall_official": [
            {
                "affiliation": "Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology", 
                "last_name": "Murat Ekin, M.D.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology", 
                "last_name": "Cihan Kaya, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Bakirkoy Dr Sadi Konuk Teaching and Research Hospital, Department of Obstetrics and Gynecology", 
                "last_name": "Mehmet E Ayag, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "We think that the urinary frequency will be lesser after 6 months of the therapy.", 
            "measure": "Urinary frequency", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01730300"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bakirkoy Dr. Sadi Konuk Research and Training Hospital", 
            "investigator_full_name": "murat ekin", 
            "investigator_title": "Training Officer of Obstetrics and Gynecology Department M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "We think that social activity will be better after reducing urinary symptoms", 
            "measure": "social activity", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "source": "Bakirkoy Dr. Sadi Konuk Research and Training Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bakirkoy Dr. Sadi Konuk Research and Training Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}